Objective: Previous research suggests that a link between anesthetic exposure and Alzheimer disease exists. Because anesthetics are rarely given alone, we ask whether addition of surgery further modulates Alzheimer disease. Background: Cognitive dysfunction occurs after surgery in humans. Anesthesia alone produces cognitive decline in both older wild-type (WT) mice and rats, and the addition of surgery produces transient decline in young, adult WT mice. Because neuroinflammation has been implicated and occurs early in Alzheimer disease, we hypothesized that the neuroinflammatory stress associated with surgery would accelerate the progression of Alzheimer disease. Methods: Cecal ligation and excision were performed on presymptomatic 5to 11-month-old triple-transgenic Alzheimer disease (3×TgAD) and C57BL/6 WT mice under desflurane anesthesia. Surgery animals were compared with aged-matched 3×TgAD and WT mice exposed to air or desflurane alone. Cognitive function was assessed via Morris water maze at 2 and 13 weeks postoperatively. Amyloid and tau pathology and inflammation and synaptic markers were quantified with immunohistochemistry, Luminex assay, enzymelinked immunosorbent assay, or Western blot assays. Results: A significant cognitive impairment in 3×TgAD mice that underwent surgery compared with air or desflurane controls persisted to at least 14 weeks after surgery. Microglial activation, amyloidopathy, and tauopathy were enhanced by surgery as compared with desflurane alone. No differences between surgery, anesthetic, or air controls were detected in WT mice Conclusions: Surgery causes a durable increment in Alzheimer pathogenesis, primarily through a transient activation of neuroinflammation.
patients. 2, 3 Furthermore, 3 independent studies showed that the diagnosis of Alzheimer disease stratified by patient age is associated with previous anesthetic exposure at odds ratios between 1.2 and 1.7. [4] [5] [6] However, a more recent study of an Alzheimer Disease Center cohort concluded that the trajectory of cognitive decline was unaltered by either surgery or major illness. 7 Shortly, after this article appeared, a larger study reported that major illness was associated with cognitive decline in older adults after hospitalization. 8 Given the effect sizes that would be considered important, all of the reported clinical studies must be considered underpowered and thus the translational question remains unanswered.
More progress has been made in animals, although ambiguity still exists. Anesthetics alone have been found to increase the production 9,10 and aggregation of amyloid-β protein, 11 central features of at least some forms of Alzheimer disease. Exposure to anesthetics alone in 2 Alzheimer mouse models 12, 13 has also revealed an acceleration of amyloidopathy without enhanced cognitive dysfunction. An acceleration of tau neuropathology has also been found after both hypothermic and normothermic 14 anesthetic exposures in young, adult wild-type (WT) mice, 15 in the tripletransgenic Alzheimer disease (3×TgAD) mouse model after normothermic anesthetic exposures, 16 and in lipopolysaccharide-induced neuroinflammation. 17 Transient cognitive dysfunction has been reported after anesthetic exposures in both older WT mice 12 and rats. 18, 19 Cognitive effects, however, have not always been observed after anesthesia alone, especially in WT and/or young rodents. 16, 20, 21 Long-term cognitive decline (>3 months) after anesthesia has not been reported in the rodent.
Because volatile anesthetics are rarely given in the absence of surgery, it is possible that the surgical procedure itself modulates the progression of Alzheimer pathology. The peripheral surgical stress response, as described in detail by Kohl and Deutschman, 22 is a complex process involving many distinct alterations of the normal physiology, including production of inflammatory mediators, increase in catabolism of skeletal and visceral muscle, increased gluconeogenesis, and increased protein synthesis. In at least one study, cognitive decline and microglial activation were observed after tibial surgery-induced systemic inflammation in WT mice. 23 Because neuroinflammation occurs early in the pathology in 3×TgAD mice, 24 we hypothesized that the significant physiological and neuroinflammatory stress associated with surgery accelerates the progression of Alzheimer pathology and consequent cognitive decline beyond that caused by the anesthetic exposure.
University of California, Irvine, CA, and elderly C57BL/6 WT mice were obtained from the National Institute on Aging, Bethesda, MD. The 3×TgAD mouse model has been shown to develop both plaque and neurofibrillary tangle neuropathology and cognitive dysfunction in an age-dependent manner. 25 Genotype was verified from tail biopsies by means of proteinase-K digestion, DNA extraction, and polymerase chain reaction. Mice were tagged with BMDS IMI-1000 subcutaneous identification tags (BioMedic Data Systems, Seaford, DE) at weaning. Both male and female mice were used in this study, and the age range from 5 to 11 months was deliberately chosen to represent a cross section of older but still presymptomatic animals that are highly reflective of the corresponding ages of patients presenting for surgery.
Surgery and Anesthetic Exposure
Three experimental conditions were examined: desflurane only (Des), desflurane plus surgery (Surg), and air controls (Con). Sex and ages of each group of mice were carefully matched to minimize confounding effects of either.
Desflurane Only
3×TgAD and WT mice were exposed to desflurane (2,2,2trifluoro-1-fluoroethyl-difluoromethyl ether) alone, with no surgery. Desflurane was chosen because it is a commonly used anesthetic in older adults and is considered less provocative than isoflurane or halothane, 26, 27 thereby improving the odds of detecting an effect due to surgery. Exposure was conducted in a heated, monitored anesthesia chamber, with humidified 40% oxygen balanced by nitrogen , initially containing 1.5 minimum alveolar concentration (11% vol/vol) desflurane and 100% oxygen flowing at 5 L/min, using a calibrated desflurane vaporizer. Desflurane concentration was reduced to 9% (vol/vol) for maintenance after loss of response to foot pinch while maintaining spontaneous respiration. Anesthetic concentrations were monitored during exposures with a Datex Engstrom Capnomac gas monitor. The duration of the exposure was less than 30 minutes, and the mice resumed full activity within 10 minutes after exposure. Chamber carbon dioxide levels never exceeded 0.1%. Rectal temperatures were monitored before and periodically during the anesthetic exposures and up to 72 hours PO and changes greater than 1 • C were not detected. Body weights were recorded before and after exposure that remained unchanged.
Desflurane and Surgery
3×TgAD and WT mice underwent desflurane anesthesia as described earlier. After induction, mice were transferred to a heated table where they were induced and maintained as described earlier (average 8.75% desflurane) with 100% oxygen at 1 L/min via a nose cone. The abdomen was shaved and cleaned with Betadine swabs. Using sterile technique, a laparotomy incision of about 1.5 cm in length, extending from just below the xiphoid process to just above the pubic symphysis, was made. The bowel was exteriorized, and the cecum was identified. Using 4.0 coated, braided silk suture, the cecum was ligated within 1 cm of the distal ileum, using care to avoid obstruction. The cecum was then excised just distal to the ligation, and the remaining proximal tip of cecum was copiously irrigated with 10 mL of normal saline to remove any fecal material. The bowel was then returned to the abdominal cavity, and the abdomen closed in 2 layers, using 4.0 coated, braided suture. A subcutaneous injection of 0.25% bupivacaine (10 mg/kg) was given at the wound edges, and a subcutaneous injection of 1 mL of normal saline for hydration. Body weights and temperatures were recorded as earlier, with no significant changes detected. The average duration of the surgery was 19 minutes (range, 14-24 minutes), and the average duration of the anesthetic exposure was 24 minutes (range, 19-30 minutes). All mice were ambulatory within 30 minutes after surgery and had returned to apparently normal activity within 24 hours. Surgical wounds healed well with no drainage, odor, or erythema. The activity of all mice before behavioral training and testing was considered normal.
Controls
Groups of comparably aged 3×TgAD and WT mice exposed to humidified 30% oxygen (balanced by nitrogen) in other ongoing studies were used to collect control behavioral data.
Behavioral Testing Morris Water Maze
Learning and memory testing was conducted using the Morris water maze (MWM) as described previously. 16 Briefly, at both time periods ( Fig. 1 ), the mice were first trained to escape from the pool (four 60-second trials per day for 5 days), followed by the behavioral testing, including reference memory testing (four 60-second trials per day for 5 days), and a probe test (one 60-second trial). In addition, spatial working memory testing was conducted at the second time point (up to 8 trials per day for 10 days). Water temperature was maintained at 23 to 26 • C with a pond heater, and there was a 30-to 45-minute interval between trials. Mice were dried off and actively warmed after each trial. Cued training (before the cognitive function behavioral tests) trained the mice to reach a flagged submerged platform to be removed from the pool. All mice learned to escape from the flagged platform. After training, reference memory testing was conducted at 2 and 13 weeks PO. This tested the ability of the mice to learn the location of the hidden platform in a fixed location from varied starting points by using fixed external visual cues in the room. Mice were tracked with a video camera mounted above the pool that fed to a computer running IMAQ PCI-1407 software (National Instruments, Austin TX). The mean escape latencies were calculated for each mouse per day. In addition, the distance traveled was recorded for each mouse during the reference memory trials, and the data were expressed as the mean distance traveled for each day. The platform was removed for the probe test that examined the ability of mice to remember the location of the platform by measuring preference for the quadrant where the platform had been located (target quadrant) over the other quadrants. The probe trial was conducted 2 hours after the final trial on the last day of the reference memory testing for each mouse (Fig. 1 ). The percentage of time spent in each quadrant, during the 60-second trial, was recorded and the ratios of the percentage of time spent in the target quadrant to the percentage of time spent in the opposite quadrant were calculated for each animal; the data were expressed as the mean of these ratios. Swim speed during the probe trial was also measured. Beginning at 12 weeks PO, the same behavioral tests were repeated for the same animals ( Fig. 1 ). In addition, spatial working memory testing was conducted beginning at 14 weeks PO as described previously. 16, 28 The criterion for this test involved locating different (preset) locations of the hidden platform 3e times in a row within 20 seconds by using external visual cues in the room. The number of trials to reach criterion for each mouse for each platform location was determined, and the mean number of trials to reach criterion per platform location was calculated.
Rotorod
Approximately 24 hours after completing the MWM tasks, Rotorod trials were conducted to assess motor and coordination effects of the surgery and desflurane groups at about 16 weeks PO. The test was conducted in 2 parts. Initially, each mouse was acclimated to the Rotorod (IITC Series 8; IITC Life Sciences Inc) with a 60-second trial at 9 rpm. After the training trial, a series of 3 test trials were conducted at 18 rpm. For the test trials, the length of time the mice remained on the rod up to a maximum of 120 seconds was recorded. When the mouse fell off the rod, the time was recorded and that test trial ended. There was a 15-minute break between each of the 3 test trials. Three trials were conducted and mean times were determined.
Statistics
All behavioral analyses were performed using GraphPad Prism 5.04 software, and animal numbers are described in the legend of 
Euthanasia and Tissue Collection
Animals that underwent behavioral studies were euthanized the day after Rotorod testing by rapid induction of deep anesthesia with halothane and then intracardiac perfusion and simultaneous exsanguination from the right atrium with ice-cold phosphate-buffered saline. The time required from loss of consciousness to brain removal was routinely less than 5 minutes, and we have never been able to document differences in brain biochemistry as compared with more conventional methods of euthanasia such as carbon dioxide inhalation or cervical dislocation (unpublished results). The brains were placed on ice and hemisected in the sagittal plane, and one side was placed in 4% paraformaldehyde and subsequently paraffin embedded, whereas the other side was immediately frozen in liquid nitrogen and stored at −80 • C for biochemical analyses.
Immunohistochemistry and Biochemistry Measurements
Amyloid and tau pathology and inflammatory and synaptic markers were quantified by immunohistochemistry, Luminex assay, enzyme-linked immunosorbent assay, or Western blot assays. In addition to the mice that underwent long-term behavioral analyses, the acute response to desflurane and surgery was assessed in additional 3×TgAD and WT mice at age range from 5 to 11 months, which were euthanized 24 hours after surgery as earlier for immunohistochemical and biochemical measurements.
Immunohistochemistry
Immunohistochemistry was performed essentially as described previously. 16 Paraffin-embedded brain sections were rehydrated and incubated with primary antibody 6E10 (1:1000; Covance, Dedham, MA) for amyloid plaque, antibody AT8 (1:500; Thermo Scientific, Waltham, MA) specific for PHF-tau doubly phosphorylated at Ser201 and Thr205, and Iba-1 antibody (1:1000; Wako Pure Chemical Industries, Japan) for activated microglia. Immunostaining was visualized using an Olympus IX70 microscope equipped with a SensiCam SVGA high-speed cooled digital camera (Cooke Corp, Auburn Hills, MI) and images of the hippocampal CA1 region and subiculum were captured at 10× magnification. The number and area occupied by plaque and tau-stained cells and the area occupied by microglial cells were quantified using IPLab Suite v4.0 Imaging Processing and Analysis software (Biovision Technologies, Exton, PA), and the mean was calculated from 3 slides per animal.
Luminex Assay
Determination of acute cytokines and chemokines levels was conducted with the Luminex assay in Human Immunology Core at the University of Pennsylvania and as described previously, 29 using frozen saline-perfused 3×TgAD and WT hemibrains homogenized at 24 hours PO. Concentrations of interleukin (IL)-1β, IL-4, IL-6, IL-10, tumor necrosis factor α, and monokine induced by IFN-γ were simultaneously quantified for each sample using the Mouse Cytokines/Chemokines Panel-5 Plex panel (Millipore catalog #MPXMCYTO-70K). In addition, using the Luminex xMAP platform, the concentration of transforming growth factor β (TGF-β) in the brain was measured with the Milliplex MAP TGF β1-Single Plex kit (Millipore catalog #TGFB-64K-01). The Luminex data, for both WT and 3×TgAD mice, were expressed as the ratio to WT controls.
Western Blot Assays
Frozen saline-perfused hemibrains from 24 hours PO 3×TgAD and WT mice were homogenized in 2% sodium dodecyl sulfate or NP40 Cell Lysis Buffer (Invitrogen catalog #FNN0021) supplemented with 1 mM of PMSF (Sigma catalog #P7626) and protease inhibitor cocktail (Sigma catalog #P-2714). Immunoblot assays were performed essentially as described previously 16 for amyloid precursor protein, C-terminal fragments, caspase-3, synaptophysin, postsynaptic density-95, and Iba-1.
Statistical Analyses
Statistics were performed for genotype and treatment using 1way or 2-way analyses of variance, as described in the figure legends. Animal numbers are indicated in the legends for Figures 4-6. All statistics were performed using GraphPad Prism 5.04 software.
FIGURE 2.
Reference memory testing. The escape latency (A-D) and path length (E-H) recorded during the reference memory testing for 3×TgAD and WT mice at 2 PO time points after surgery (Surg) or desflurane alone (Des) compared with controls (Con). No changes were found in the escape latencies for WT mice at either 2 or 13 weeks PO (A, C), but significant treatment effects were found for 3×TgAD surgical mice at both 2 and 13 weeks PO compared with controls, with test days 2 to 5 showing significantly longer escape latencies with Bonferroni posttests (B, D). A nonsignificant trend was found at 2 weeks for the desflurane group compared with controls (day 2, P = 0.093; day 4, P = 0.057). The mean path length during the reference memory testing also showed an overall significant surgical effect at both 2 and 13 weeks PO for the 3×TgAD surgical mice (F, H), with 2 test days showing significantly different path lengths. Animal numbers for panels A and E, WT: Con n = 14, Des n = 14, Surg n = 16; panels B and F, 3×TgAD: Con n = 40, Des n = 14, Surg n = 16; panels C and G, WT: Con n = 25, Des n = 12, Surg n = 14; panels D and H, 3×TgAD: Con n = 34, Des n = 12, Surg n = 12. Key in panel A is the same for all panels, black (control), blue (desflurane), red (surgery). For all graphs, data expressed as means ± SEM. Significance determined for both analyses by repeated measures 2-way analysis of variance with Bonferroni post hoc testing, * P < 0.05, †P < 0.01, ‡P < 0.001. SEM indicates standard error of the mean.
RESULTS

Behavior
Escape Latency
The escape latencies showed no changes at either 2 or 13 weeks PO in the WT mice ( Figs. 2A, C) , but a significant treatment effect was found in 3×TgAD surgical mice compared with air controls at both 2 (Fig. 2B ) and 13 weeks PO (Fig. 2D ). The desflurane group was not significantly different from the controls in either WT or 3×TgAD groups at either time point, although there was a trend in the 3×TgAD group at 2 weeks PO. The mean path lengths for the 5 days of reference memory testing were determined, and no differences were found in the WT groups (Figs. 2E, G), but significantly increased path lengths were observed for the 3×TgAD surgical mice compared with controls at both 2 and 13 weeks PO (Fig. 2F, H) . Path length, unlike escape latency, is independent of swim speed. Both of these analyses indicate that the surgical 3×TgAD mice were cognitively compromised at both 2 weeks and FIGURE 3. Probe and spatial working memory tests. A, B, When probe test results are compared by genotype, the mean of the ratios of the percentage of time spent in the target quadrant to the opposite quadrant, a decline in all of the 3×TgAD mice is apparent at 2 weeks. At 13 weeks PO, a significant decline was observed in the 3×TgAD surgical mice as compared with their controls (B). C, Spatial working memory testing conducted at 14 weeks PO showed that the surgery of 3×TgAD mice performed significantly less well than their controls. D, E, Swim speeds recorded during the 60-second probe test at 2 and 13 weeks PO showed that the WT anesthetic and surgical mice and the 3×tgAD surgical mice had decreased swim speeds compared with controls, although the Rotorod data (F) indicates that all mice have the same motor ability. Animal numbers for panels A and D, WT: controls (Con) n = 14, desflurane alone (Des) n = 14, surgery (Surg) n = 16; 3×TgAD: Con n = 40, Des n = 14, Surg n = 16; panels B, C, E and F, WT: Con n = 25, Des n = 12, Surg n = 14; 3×TgAD: Con n = 34, Des n = 12, Surg n = 12. Key in panel A is the same for all panels. For all graphs, data expressed as means ± SEM. Statistical significance determined by 2-way analysis of variance with Bonferroni posttests, * P < 0.05, †P < 0.01, ‡P < 0.001. SEM indicates standard error of the mean.
3 months PO, despite having been trained before testing at both time points.
Probe Test
A significant transgene effect was found at the 2-week time point for the probe test (Fig. 3A, B) , and a treatment effect was found for the 13-week PO probe test, with the 3×TgAD surgical groups performing significantly poorer than their controls (Fig. 3B ). This significant effect for the surgical 3×tgAD mice is also found when all quadrants were compared (see Figure 
Spatial Working Memory
The number of trials to reach criterion per platform location was determined beginning at 14 weeks PO, with a lower number of trials reflecting better performance. The 3×TgAD mice that underwent surgery performed significantly less well than the air controls ( Fig. 3C ). No significant differences were found in the WT groups. It should also be noted that the 3×TgAD controls performed as well as the WT controls on this behavioral assay.
Motor Skills
During the 60-second probe test, swim speed was also recorded (Figs. 3D, E), with significant differences for both WT and 3×TgAD anesthetic and surgery mice compared with their controls. Rotorod testing at 16 weeks PO revealed no differences in motor or coordination ability between the surgery and desflurane-only treated animals (Fig. 3F ).
Immunohistochemistry (24 Hours and 16 Weeks PO) Amyloid-β and Tau
After completion of the behavioral testing (16 weeks PO), euthanasia and brain harvest, amyloid-β plaque density was quantified in the subiculum in 3×TgAD mice with immunohistochemical localization of 6E10 (Figs. 4A-C). Phosphorylated tau (pTau) was detected with the AT8 antibody ( Fig. 4D-F) . Only a nonsignificant trend for higher plaque density in the surgery group as compared with the desflurane group was noted ( Fig. 4C ). On the contrary, a highly significant increase in the number of pTau-positive neurons was found in the 3×TgAD surgery group, with the greatest numbers of tau aggregates found in the subiculum (Fig. 4H ). Wild-type mice were not examined because amyloid plaque and pTau (human isotope) are generally not detectable.
Activated Microglia
The number of activated microglia at 24 hours and 16 weeks PO was quantitated with Iba-1 immunohistochemistry in the CA1 region and the underlying molecular layer of the dentate gyrus of the hippocampus in both WT (Figs. 5A-C) and 3×TgAD mice (Figs. 5D-F). At 24 hours PO, a significant increase in activated microglia was found in the surgery groups in both 3×TgAD and WT mice, with the largest increase observed in the Alzheimer transgenic mice (Fig. 5G) . However, at 16 weeks PO, no differences in microglia were detected in any group (Fig. 5H ).
FIGURE 4.
Immunohistochemistry of Alzheimer markers in the 3×TgAD mouse subiculum at 16 weeks PO. A-C, Representative sections stained for amyloid-β (6E10 antibody) from the controls, desflurane, and surgery groups, respectively, with quantitation (G). Controls (Con) (n = 13, white bar), desflurane (Des) (n = 13, gray bar), and surgery (Surg) (n = 12, black bar). D-F, Representative sections of immunohistochemical localization of pTau (AT8 antibody) for control, desflurane, and surgery respectively, with quantitation (H). Con (n = 13, white bar), Des (n = 14, gray bar), and Surg (n = 11, black bar). For all graphs, data expressed as means ± SEM. Bar = 100 μm. Statistical significance determined by 1-way analysis of variance with Bonferroni posttests, * P < 0.05, †P < 0.01. SEM indicates standard error of the mean. saline perfused at euthanasia to minimize cytokine contamination arising from blood. Significant treatment, genotype, and interaction effects were found with IL-10 ( Fig. 6A ). IL-10 levels increased after desflurane or desflurane and surgery in WT mice but only in the 3×TgAD animals that were exposed to desflurane only. IL-10 levels were unaltered in the 3×TgAD animals treated with both desflurane and surgery, perhaps reflecting unopposed proinflammatory effects in the transgenic brain after surgery. No significant changes were found for TGF-β, IL-1β, or tumor necrosis factor α (Figs. 6B-D). A significant treatment and genotype effect was found for the chemokine, monokine induced by IFN-γ (Fig. 6E ). IL-4 and IL-6 levels were undetectable with Luminex assays in the brain at 24 hours PO.
Western Immunoblots
Significant differences were not detected in 3×TgAD and WT whole-brain homogenates for amyloid precursor protein, C-terminal fragments, caspase-3, synaptophysin, postsynaptic density-95, and the microglial marker, Iba-1, at 24 hours PO (see Figure, Supplemental Digital Content 2, available at http://links.lww.com/SLA/A284, for the Western blot results). This may be due to the use of whole-brain homogenates and thus dilution of regional effects.
FIGURE 5.
Immunohistochemistry of activated microglia in WT and 3×TgAD mice. Representative sections through the hippocampal CA1 region in WT (A-C) and 3×TgAD mice (D-F) at 24 hours PO stained for activated microglia (Iba-1 antibody), showing control (A, D), desflurane (B, E), and surgery (C, F) micrographs. Bar = 100 μm. Quantitation for WT and 3×TgAD animals at both the 24 hours and 16 weeks PO time points are shown in panels G and H, respectively. Controls (Con) (white bars), desflurane (Des) (gray bars), and surgery (Surg) (black bars). Animal numbers at 24 hours PO (G) for WT: Con (n = 5), Des (n = 5), Surg (n = 6) and for 3×TgAD: Con (n = 4), Des (n = 6), and Surg (n = 5), and at 16 weeks PO (H) for WT: Con (n = 13), Des (n = 10), Surg (n = 13) and for 3×TgAD: Con (n = 14), Des (n = 11), and Surg (n = 10). For all graphs, data expressed as means ± SEM. Statistical analyses used 2-way analysis of variance with Bonferroni posttest, * P < 0.05. SEM indicates standard error of the mean.
abdominal surgical procedure to a brief inhalational anesthetic in the context of the brain made vulnerable by human Alzheimer-associated transgenes. The surgical procedure roughly mimics appendectomy or colectomy, exceedingly common procedures received by millions of patients annually. There are 2 important points to consider regarding this result. First, at the time of surgery and even 3 months later, this control 3×TgAD animal was essentially asymptomatic; its baseline learning and memory were not different from those of the WT animals despite having evidence of ongoing neuropathology. This is likely to well represent both the age range and cognitive status of many of our patients presenting for a surgical procedure and suggests the window of vulnerability extends into this presymptomatic period. Previous work in a slightly different murine Alzheimer model (Tg2576) suggested that vulnerability to interventions might be lost when the animals demonstrate significant cognitive impairment, 12 termed a "floor effect," although surgery was not part of the intervention. Second, the WT animal demonstrated no significant cognitive sequelae from either the anesthetic or the surgery. This is in contrast to previous work in which surgery caused a pronounced transient cognitive decline in WT rodents, with complete resolution of the cognitive deficits 6 . Early (24 hours PO) changes in brain cytokines/chemokines using Luminex assays. Controls (Con) (white bars), desflurane (Des) (gray bars), and surgery (Surg) (black bars); n = 12 for all groups. A, Desflurane exposure increased IL-10 in both WT and 3×TgAD animals, but the addition of surgery significantly increased IL-10 levels further in the WT animals and abolished the increase in 3×TgAD mice. B, Likewise, MIG levels were found to be increased in the desflurane exposures only, and the 3×TgAD animals had a significantly larger response in general than in WT animals. C-E, No significant treatment or genotype effects could be detected in IL-1β, TGFβ, or TNF-α. For all graphs, data expressed as means ± SEM. Statistical analyses used 2-way analysis of variance with Bonferroni posttest, * P < 0.05. MIG indicates monokine induced by IFN-γ ; SEM, standard error of the mean; TNF-α, tumor necrosis factor α.
by PO day 7. 23, 30 Although the surgical procedures were different, the likely explanation for our inability to see an effect on the WT animal is time. We did not begin testing until 14 days after surgery to ensure that animals were well beyond the pain and recovery phase of the surgery. Thus, it is possible that our WT animals also suffered a transient cognitive decline in the first week after surgery, but our hypothesis was focused more on the long-term effects.
The basis for slower swim speed in the surgical groups is not clear, as the animals had no signs of pain or altered movement and were feeding and grooming normally. It is possible that this observation confounded the behavioral tests, specifically the escape latency, a time, and therefore swim speed-dependent task. However, several observations argue against this. First, the WT mice had the same decrement in swim speed (Figs. 3D, E), but no alteration in escape latency at either 2 or 13 weeks PO ( Figs. 2A, C) . Second, the same task can be analyzed in a swim speed independent manner by measuring the escape path length, which was also significantly elevated in the surgery group (Figs. 2F, H) . Third, another MWM swim speed independent task, the probe test, was definitive in its demonstration of impaired memory in the transgenic surgery mice (Fig. 3B) . Finally, the Rotorod test, a test of both coordination and motor function, was unaltered in the surgery mice ( Fig. 3F ). Taken together, these 4 observations effectively rule out the contribution of swim speed alterations to the deficits attributed to learning and memory.
The brain vulnerability studied here may not translate completely to the human situation. The 3×TgAD model, like all current murine models of Alzheimer disease, more closely resembles the situation in familial Alzheimer disease (an overproduction of aggregating protein species), which constitute only a small minority of patients with Alzheimer disease. Thus, it is not yet clear whether results from this kind of model well represent most of our patients who have, or will eventually get, late-onset (sporadic) Alzheimer dis-ease. However, these models are currently the standard of choice for screening new Alzheimer drugs and have yielded considerable insight into Alzheimer pathogenesis. Furthermore, the 3×TgAD animal most closely recapitulates the essential neuropathological hallmarks of even late-onset Alzheimer disease, such as extracellular senile plaque, intracellular neurofibrillary tangles, and synaptic dysfunction. 25 Finally, the order of progression of the pathology is consistent with human late-onset disease. Thus, although triggering details of the model imperfectly represent most human Alzheimer disease, the general features suggest translatability.
The underlying mechanism for the cognitive effects observed here seems to be triggered by peripheral inflammation, consistent with previous studies that show lipopolysaccharide injection enhances both neuroinflammation, cognitive decline, and Alzheimer pathogenesis in several transgenic mouse models (1977, 1615, 2092) . In this study, in both the middle-aged WT and 3×TgAD animals, the addition of surgery caused an early increase in Iba-1 immunoreactivity in the brain. This is probably due to microglial activation, although attraction of other cell types (monocytes) to the brain, via a leaky bloodbrain barrier, cannot be fully ruled out. Regardless, this suggests an inflammatory process, which is well known to occur as a result of surgery, at least in the periphery. 22 It is also well known that this peripheral inflammatory response, at least as marked by cytokines, is dampened in the brain, perhaps explaining our inability to detect significant changes in brain tissue. It might be important to note that we carefully cleared the brain of blood during euthanasia to exclude the possibility of cytokine/chemokine contamination from blood, which is known to be very rich in these molecules after surgery. 22 This initial acute inflammatory response is clearly not sustained. The differential Iba-1 immunoreactivity is absent at 16 weeks PO, suggesting a return to baseline conditions. It is possible that whole-brain homogenates obscured regional influences, but despite this, the effect on the ongoing Alzheimer pathogenesis is indicated by the pronounced difference on τ phosphorylation and the suggestion of increases in amyloid-β plaque.
In previous studies, we and others have demonstrated that the anesthesia alone caused a delayed cognitive decline and/or a change in neuropathology in Alzheimer mice 12, 16 and in aged WT rats 18, 19, 31 and mice. 12 In contrast, in this study, the anesthetic alone here was not associated with a significant change in cognition or neuropathology. The likely reasons are 2-fold. First, the previous studies used isoflurane, isoflurane with nitrous oxide, or halothane, the former of which has been implicated in a wide variety of neurological insults. 32 Halothane is no longer used because of its greater metabolic breakdown and association with hepatotoxicity. Desflurane, although understudied in this context, has been less associated with cognitive problems or neurotoxicity and, therefore, a preferable drug for revealing an increment due to surgery. Desflurane is very commonly used for surgical anesthesia in elderly patients. The second major difference between this study and previous studies is the duration of exposure. We only kept the animal anesthetized for as long as it took to perform the surgery, never more than 30 minutes. Previous work has suggested that neurotoxicity is a function of both concentration and duration of exposure. 32 Thus, the lack of significant effects of the anesthetic here should not necessarily be viewed as exonerating desflurane. It is possible that significant effects would emerge with longer exposures, as suggested by the trend for worse cognition at 2 weeks after exposure to desflurane alone.
A syndrome called "PO cognitive dysfunction," or PO cognitive decline, has been coined to refer to the commonly reported loss of cognitive abilities, usually in older adults, in the days to weeks after surgery. Much studied, postoperative cognitive decline has not been convincingly demonstrated to persist after 3 months in people, thus it seems to be either reversible or, in some manner, compensated for. However, in this study, the cognitive deficits after surgery were essentially unchanged after 4 months in the 3×TgAD mouse, suggesting a lasting and perhaps irreversible effect. Thus, these results suggest that the interaction between surgery, inflammation, and an Alzheimer-prone brain produces an acceleration of pathology that cannot be compensated for. The IL-10 results are intriguing in this regard. IL-10 is considered to be anti-inflammatory, and generally follows the proinflammatory response, presumably to dampen it. The lack of this response in the 3×TgAD model suggests a dysfunctional anti-inflammatory mechanism, perhaps explaining the continued and durable effects on tau and cognition. Figure 7 is a hypothetical model for the relationships between surgery, inflammation, and long-term cognitive decline. Anesthesia is included in this figure with surgery because of the inseparable nature and to recognize the common use of more provocative drugs, such as isoflurane. Regardless of the underlying mechanism, the results reported herein have implication for surgery in all of our elderly patients because we do not yet routinely test for Alzheimer disease risk factors. If these results are reproduced and translate to people, then further research in animals will be required to develop protective strategies, such as the routine perioperative use of anti-inflammatory drugs in elderly patients.
In summary, we demonstrate that the combination of surgery and anesthesia produces a persistent and possibly irreversible decrement in memory and learning in a murine model of Alzheimer disease, which is associated with initial neuroinflammation and an increase in Alzheimer neuropathology, especially tauopathy.
